KFDA - NewsChannel 10 / Amarillo, TX: newschannel10.comWatson 3Q profit falls 11 percent on taxes, costs

Watson 3Q profit falls 11 percent on taxes, costs

Posted: Updated:

MORRISTOWN, N.J. (AP) - Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.

Watson said profit declined to $63 million, or 55 cents per share, from $71.1 million, or 62 cents per share, a year ago. Watson said it earned 66 cents per share, excluding impairment charges and other one-time costs.

Revenue rose 3 percent to $662.1 million from $640.7 million.

Analysts polled by Thomson Reuters expected profit of 65 cents per share on revenue of $688.5 million.

Revenue from Watson's generic drug business grew 9.4 percent to $398 million, while revenue from branded drugs rose 6 percent to $112.7 million. Distribution revenue fell 11 percent to $151.4 million.

Meanwhile, the company's income tax provision rose 71 percent to $39.3 million.

Looking ahead, the company expects adjusted profit between $2.50 and $2.58 per share for the full year, on revenue of about $2.7 billion. Analysts expect profit of $2.55 per share on revenue of $2.76 billion.

Shares of Watson fell 23 cents to $35.11 in morning trading.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Weather in the Classroom

Here is where you will find your Weather in the Classroom information.

NewsChannel 10 Tax Guide

Click here to find daily tax tips, forms, rules, and FAQ's. Brought to you by Jackson-Hewitt.

>Video, Stories and much more.

Find out what and when programs come on NewsChannel 10.

Entertainment

Click here to find out what's happening in Music, Movies, Television, and Video Games

Link to the Official Texas Lottery website to see if you have won!

Click here to view a large selection of online games and downloads.

Powered by WorldNow
All content © Copyright 2000 - 2010 WorldNow and KFDA. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.